Provided by Tiger Trade Technology Pte. Ltd.

Tema Heart & Health ETF

36.22
+0.51001.43%
Post-market: 36.220.00000.00%19:30 EDT
Volume:683
Turnover:24.64K
Market Cap:53.60M
PE:- -
High:36.22
Open:35.75
Low:35.75
Close:35.71
52wk High:38.87
52wk Low:31.87
Shares:1.48M
Float Shares:1.48M
Volume Ratio:0.23
T/O Rate:0.05%
Dividend:0.47
Dividend Rate:1.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New Phase 3B Data Show Lilly's Ebglyss (Lebrikizumab-Lbkz) Delivered Significant and Rapid Improvements in Skin Clearance, Itch, Pain, and Patient Satisfaction in People with Moderate-to-Severe Hand and Foot Atopic Dermatitis

THOMSON REUTERS
·
Sep 30

Eli Lilly - Treatment-Emergent Adverse Events in 41.8% Ebglyss Patients, 39.6% Placebo, All Mild or Moderate

THOMSON REUTERS
·
Sep 30

Eli Lilly - Submits Ebglyss Adtouch Data to FDA and Plans Global Regulatory Submissions for Label Update

THOMSON REUTERS
·
Sep 30

Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded it to Sell

Dow Jones
·
Sep 30

Marka S.A. Pays Twelfth Installment Under Amended Bondholder Arrangement

TIPRANKS
·
Sep 30

Roche unit launches LightMix Newborn TREC/SMN1/HBB kit

TIPRANKS
·
Sep 30

Roche’s Genentech announces FDA approves NDA for fenebrutinib

TIPRANKS
·
Sep 30

Roche's BTK Inhibitor Filing Accepted for Review

Stock News
·
Sep 30

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

TIPRANKS
·
Sep 30

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Reuters
·
Sep 30

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS
·
Sep 30

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Sep 30

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS
·
Sep 30

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS
·
Sep 30

US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO

Reuters
·
Sep 30

Cboe data shows mixed options sentiment in UnitedHealth with shares down 1.58%

TIPRANKS
·
Sep 30

Cigna: Announces Exclusive Agreement with UnitedHealth Global to Endorse Ghb as Preferred International Health Insurer - Website

THOMSON REUTERS
·
Sep 29

Cigna Global Health Benefits Signs Exclusive Endorsement Deal with UnitedHealthcare Global

Reuters
·
Sep 29

Roche's New Breast-Cancer Drug Supports Midterm Growth Outlook

Dow Jones
·
Sep 29

Roche Shows New Research-and-Development Approach is Bearing Fruit

Dow Jones
·
Sep 29